compound tirzepatide shortage FDA says years-long is resolved, will give limited leeway to compounders led and built for women Compounded Tirzepatide Weight Loss Program

1 As of 2025, roughly 10 million Americans 2 are on GLP-1s, for both treatment of type 2 diabetes and weight loss, and that number is expected to reach 25 million by 2030

55 Glute Bridges: Works glutes and hamstrings

PlexusDx's medical team can help you weigh these considerations during your initial consultation to select the medication most likely to work for your body

Knowing what causes these symptoms and how to manage them keeps your weight loss journey on track

The prevalence of endothelial dysfunction in patients with and without coronary artery disease

The food tech company recently dropped a new botanical blend formula for weight management that aims to enhance the bodys natural ability to produce more of its own GLP-1